CSR Report

Overview

The report highlights Dermapharm's acquisition of Arkopharma and its continued resource-efficiency work. It added 1,172 MWh of photovoltaic specific yield in 2023 and reported no fatal workplace accidents. The report also presents EU Taxonomy disclosures, including 56.0% taxonomy-eligible turnover and 17.1% eligible CapEx.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Publication date: 28 March 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services